Location: Central, Hong Kong, Hong Kong
CIK: 0001668029 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: May 17, 2021
Total Value: $34.4M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| LUNG | PULMONX CORP | 303,030 | $20.91M | 60.8% | $69.02 * | $48.97 | 0.0% | COM | 745848101 |
| AVIR | ATEA PHARMACEUTICALS INC | 300,000 | $12.53M | 36.4% | $41.78 * | $32.23 | 0.0% | COM | 04683R106 |
| — | AEGLEA BIOTHERAPEUTICS INC | 112,044 | $882K | 2.6% | $7.87 | $7.87 | — | COM | 00773J103 |
| — | DIFFUSION PHARMACEUTICALS IN | 89,848 | $71,000 | 0.2% | $0.79 | $0.79 | — | COM PAR | 253748305 |